Host: Mario R. Nacinovich, Jr., MSc Guest: Anthony Dragun, MD One of the biggest challenges facing oncologists was the lack of standardized treatment practices for patients with hereditary breast cancers. But now that representatives from three major oncology societies have met to remedy that issue, Dr. Anthony Dragun from the MD Anderson Cancer Center at Cooper University Hospital joins us to review the latest recommendations.

Host: Jennifer Caudle, DO Guest: Stephanie L. Graff, MD Open communication can greatly impact how a patient is able to cope with the difficult emotions that often accompany a breast cancer diagnosis. Joining us to share how her own experience of being a physician-turned-caregiver for her father who was diagnosed with cancer influenced her own approach to counseling patients is Dr. Stephanie Graff, Director of the Breast Cancer Program for the Sarah Cannon Cancer Institute.

Host: Matt Birnholz, MD Guest: Antonio di Meglio, MD Joining Dr. Matt Birnholz is medical oncologist Dr. Antonio di Meglio, whose research team pursued questions on the extent to which patient lifestyle factors, such as physical activity, smoking, and alcohol consumption, change in the months and years following breast cancer diagnosis.

Host: Matt Birnholz, MD Guest: Slavica Janeva, MD Despite the increasing number of elderly patients diagnosed with breast cancer, few clinical trials focus on this age group. That’s why Dr. Slavica Janeva's team focused on the impacts of adjuvant chemotherapy on survival rates in this patient population, the results of which may change clinical practice paradigms moving forward, as he discusses with Dr. Matt Birnholz.

Host: Matt Birnholz, MD Guest: Nadine Tung, MD Recorded live at the 2019 San Antonio Breast Cancer Symposium, Dr. Matt Birnholz sat down with Dr. Nadine Tung, Associate Professor of Medicine at Harvard Medical School and Director of the Cancer Risk and Prevention Program at Beth Israel Deaconess Medical Center, to talk about her presentation on genetic testing for hereditary breast cancer.

Host: Matt Birnholz, MD Guest: Giuseppe Curigliano, MD, PhD Known for his early drug development research for breast cancer, Dr. Giuseppe Curigliano joins Dr. Matt Birnholz at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain to talk about the latest research in treatment developments for triple-negative breast cancer as well as insights on what’s coming ahead on the future horizons for this cancer subtype.